Drug discovery is where this becomes strategic. Instead of manually stitching databases: → ADMET evaluation → Drug-likeness scoring → Repurposing signals via disease pathway and drug-target mapping → Multi-omics integration → Regulatory network inference and regulon activity scoring 100+ biomedical tools and thousands of recent papers unified into reproducible workflows. This is how you scale insight across labs and teams.
→ View original post on X — @ronald_vanloon, 2026-04-11 08:30 UTC